Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

ACTIVE_NOT_RECRUITING
A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
Description

Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications, specifically using Campath as induction, for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episodes.